MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202641056116 A) filed by B. S. Abdur Rahman Crescent Institute Of Science And Technology on May 02, 2026, for Nanoformulation For Diabetics Management.
Inventors include Dr. S. Hemalatha; Dr. S. Ranjani; and A Reema.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present subject matter is a nanoformulation comprising silver nanoparticles capped with the Myristica fragrans leaf extract (MfAgGNF). The formulation is promising as a use for diabetic management.
Disclaimer: Curated by HT Syndication.